Experimental obesity drug avoids brain effects that troubled predecessors

Links shared publicly online about this topic.

1,028
total visits

Experimental obesity drug avoids brain effects that troubled predecessors

Stockholm, Sweden: A second-generation experimental anti-obesity and diabetes drug has shown promise in reducing body weight in rodents just as effectively as the predecessor rimonabant while avoiding the risk of psychiatric side effects that led to the withdrawal of rimonabant from the market and stopped ...

View full resource at physorg.com

Tags: Diabetes, Diabetes Medication, Obesity, Obesity Medication, Brain, Drug, Accomplia